Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
156.88
+2.03 (1.31%)
May 4, 2026, 12:55 PM EDT - Market open
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.17 billion as of May 4, 2026. Its market cap has increased by 233.77% in one year.
Market Cap
6.17B
Enterprise Value
5.68B
1-Year Change
233.77%
Ranking
Category
Stock Price
$156.88
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.17B, an increase of 4,168.92%. That is a compound annual growth rate of 155.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 6.09B | 1.52% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 6.59B |
| Protagonist Therapeutics | 6.28B |
| Cogent Biosciences | 6.26B |
| Centessa Pharmaceuticals | 6.12B |
| Terns Pharmaceuticals | 6.11B |
| Celcuity | 6.07B |
| Spyre Therapeutics | 5.99B |
| Apogee Therapeutics | 5.96B |